Background
Mitogen activated protein (MAP) kinase pathways are a broadly conserved mechanism for transducing extracellular signals that regulate cell growth and development (see [1] for review). In mammalian cells, the canonical MAP kinase cascade, composed of Raf, MEK (dual-specificity ERK kinase) and ERK (extracellular signal-regulated kinase), is regulated by the Ras GTPase in response to activation of growth factor receptors [2] . Ras-dependent activation of Raf kinase initiates activation of the ERK MAP kinase cascade, which transmits information to the nucleus and results in the regulation of genes involved in growth control [3] . Another related MAP kinase cascade is the Jun N-terminal kinase (JNK) pathway, composed of MEKK (MEK kinase-1), JNKK (JNK kinase) and JNK (Jun N-terminal kinase) [4, 5] ; this pathway is also termed the stressactivated protein kinase (SAPK) pathway. The JNK MAP kinase pathway has been shown to be activated by numerous factors, including protein-synthesis inhibitors, tumour necrosis factor ␣ (TNF␣), and ultraviolet light. In a striking parallel to the control of the Raf-MEK-ERK pathway by Ras, the JNK pathway has recently been shown to be activated by the Rho family GTPases, Cdc42 and Rac1 [6] [7] [8] . In previous studies, members of this family have been shown to be important regulators of cytoskeletal polarization and actin rearrangements in both mammalian cells and yeast [9] [10] [11] [12] [13] [14] [15] . In fibroblasts, Rho can induce the formation of actin stress fibers [12, 13] , whereas Rac1 can regulate membrane ruffling and lamellipodia formation [14] . Yeast Cdc42 is necessary for polarity during cell division by budding [9] , and mammalian Cdc42 has recently been shown to be involved in T-cell polarization [10] and in the formation of filopodia in fibroblasts [11, 15] .
The downstream targets of Cdc42 or Rac1 that are responsible for JNK1 kinase activation or cytoskeletal organization have not been clearly defined. Several candidate effectors have been described, including the p21 Cdc42-or Rac-activated serine/threonine kinases (PAKs) [16] [17] [18] [19] , the ACK non-receptor tyrosine kinase (ACK: activated Cdc42-associated kinase) [20] , lipid kinases [21, 22] , GTPase-activating proteins [23] , and a myosin-related molecule [24] . Many of the functions of Cdc42 in yeast seem to be mediated by the serine/threonine kinases Ste20 and Cla4 [25, 26] . Ste20 functions in the activation of the yeast pheromone response MAP kinase cascade, consisting of Ste11, Ste7, and Fus3/Kss1, and seems to coordinate inputs from both a heterotrimeric G protein and Cdc42 [1, [25] [26] [27] [28] . Interestingly, Ste20 has recently been shown to share an important role with the Cla4 kinase in regulating cellular morphogenesis [26] .
In this study, we sought to investigate the role of mammalian members of the PAK/Ste20 kinase family in mediating the effects of Cdc42 and Rac1. We have cloned a novel human PAK kinase, hPAK1, and used yeast molecular genetics to identify a potent constitutive hPAK1 allele. Through expression of constitutive hPAK1 kinase in mammalian cells, we have found that hPAK1 specifically activates the JNK1 MAP kinase pathway in a manner analogous to the activation of the mating MAP kinase pathway by Ste20 in yeast.
Results

Identification of a human Ste20 homologue, hPAK1
To initiate studies of mammalian Ste20-related kinases, we used an approach based on the polymerase chain reaction (PCR) to isolate a PAK isoform, hPAK1, from a human placental cDNA library [29] ( Fig. 1 ; GenBank accession number U51120). The amino-acid sequence of hPAK1 is predicted to be 98 % identical to the originally described rat PAK [16] , differing at eight of 545 aminoacid residues (boxed in Fig. 1 ). The hPAK1 protein shares 52 % identity with Ste20 in the amino-terminal Cdc42-binding regulatory domain and 70 % identity in the carboxy-terminal kinase domain [25] .
hPAK1 can function as Ste20 in budding yeast
The extent of similarity between hPAK1 and Ste20 prompted us to examine the extent of functional conservation between these kinases. We therefore expressed hPAK1 from the inducible GAL1 promotor in yeast and assayed for complementation of the ste20-null mating defect [25] . Expression of wild-type hPAK1 efficiently restored mating of ste20-null cells to near wild-type Ste20 + levels (Fig. 2) . As expected, cells expressing catalytically inactive hPAK1 K299A or vector alone remained unable to mate. Further examination of the ste20 cells expressing hPAK1 suggested that other pheromone-induced responses were normal; these responses included cell-cycle arrest, induction of a transcriptional reporter (FUS1::lacZ; [30] ), and the mating ''shmoo'' morphology (data not shown). As expected, the ability of PAK to function in yeast was dependent upon the Ste11 kinase, which is the MAPKKK (MAP kinase kinase kinase) of the mating response pathway (J.L.B., unpublished observations) and the immediate downstream target of Ste20 [1] . These results show that the hPAK1 and Ste20 kinases are highly related in function, and that heterologous expression of hPAK1 is sufficient to coordinate the known Ste20-dependent mating responses in yeast.
Identification of a constitutively active hPAK1
To study the function of hPAK1 in mammalian cells, we exploited the finding that hPAK1 complemented ste20 to identify a constitutively kinase-active hPAK1. A plasmid encoding hPAK1 was chemically mutagenized and transformed into yeast (see Materials and methods for details). As induction of the mating response normally results in cell-cycle arrest before conjugation [1] , we sought hPAK1 alleles that slowed growth when expressed. We identified a single allele of hPAK1 that slowed growth and simultaneously induced FUS1::lacZ expression, indicating that this allele may encode a constitutive kinase. This allele remained biologically active when tested for its ability to complement the mating defect of the ste20 strain (Fig. 2) . The activating mutation encoded a change of leucine to phenylalanine at position 107 (L107F), a highly conserved residue among the Cdc42-binding domains of Ste20/PAK family members [16] [17] [18] [19] [20] .
hPAK1 L107F is a potent constitutive kinase
To determine if the hPAK1 L107F allele encoded a constitutively active kinase, we compared the relative kinase activity of hPAK1 L107F to that of that of wild-type hPAK1 or hPAK1 induced by GTP-bound forms of Cdc42 or Rac1 (Fig. 3) . When expressed in COS-7 cells, wild-type hPAK1 activity (lane 2), was induced approximately 40-fold when coexpressed with Cdc42 G12V (lane 5), or 16-fold when coexpressed with Rac1 G12V (lane 6). Coexpression of RhoA G14V (lane 7) had little effect on hPAK1 activity, confirming the specificity of activation by Rac1 and Cdc42, as previously described [6] [7] [8] . Remarkably, the kinase activity of hPAK1 L107F (lane 3), was comparable to that of hPAK1 induced by Cdc42 G12V (lane 5) or Rac1 G12V (lane 6). The constitutive activity of hPAK1 L107F was affected slightly (less than 2-fold) when cells were cotransfected with activated (G12V) or dominant-negative (D57Y) forms of Cdc42 (J.L.B. and L.S., unpublished observations). These results indicate that hPAK1 L107F is constitutively active and suggest the L107F substitution in the Cdc42-binding domain bypasses the need for GTPase activation.
Interestingly, stimulation of the hPAK1 kinase activity, by the hPAK L107F mutation or by Cdc42 G12V , resulted in a mobility shift corresponding to approximately 5 kDa which most likely results from autophosphorylation, as observed previously [16] (Fig. 3) . Phosphatase treatment confirmed that this shift was due to phosphorylation of hPAK1 (data not shown). The correspondence between the phosphorylated forms of hPAK1 observed with both GTPase stimulation and the constitutively active hPAK1 L107F kinase, provides further evidence that the hPAK1 L107F allele mimics GTPase activation in vivo.
hPAK1 links Cdc42 and Rac1 to the JNK1 MAP kinase pathway
Recently, Cdc42 G12V and Rac1 G12V have been shown to regulate the activity of the JNK pathway [6] [7] [8] ; we therefore asked whether hPAK1 also plays a role in the activation of this pathway. The results in Figure 4 show that expression of wild-type hPAK1 (lane 3) or kinase-inactive hPAK1 K299A (lane 4) in COS-7 cells had little effect on the kinase activity of JNK1, as compared to the basal JNK1 activity seen in transfections with vector alone (lane 2). In contrast, expression of hPAK1 L107F strongly induced the activity of JNK1 towards c-Jun (lane 5). The level of JNK1 activity induced by hPAK1 L107F was comparable, although not identical, to 
Predicted sequence of hPAK1. Nucleotide and predicted amino-acid sequence of human hPAK1. The predicted Cdc42-binding domain (amino-acid residues 75-132) and the kinase domain (amino-acid residues 270-516) are underlined. The amino-acid residues that are different from the previously identified rat brain PAK [16] are boxed. The position of the leucine to phenylalanine substitution in hPAK L107F , which renders the kinase constitutively active, is indicated by the asterisk.
the level of JNK1 activity produced by expression of Cdc42 G12V or Rac1 G12V (lanes 6 and 7), or by ultraviolet treatment (lane 9). The specific induction of JNK1 kinase activity by the hPAK1 L107F allele, along with activation of hPAK1 by Cdc42 G12V or Rac1 G12V (Fig. 3) , argues that hPAK1 acts directly in the JNK1 MAP kinase pathway to mediate communication between Cdc42/Rac1 GTPases and the MEKK kinase (a MAPKKK). This possibility is further supported by our observation that hPAK1 function in yeast is directly dependent on the analogous MAPKKK, Ste11.
hPAK1 does not activate the ERK MAP kinase pathway
To address the possibility that activation of the JNK1 pathway by hPAK1 L107F reflected a non-specific activation of MAP kinase pathways, we tested the effects of hPAK1 L107F on the Raf-MEK-ERK pathway (Fig. 5 ). It has previously been shown that expression of activated Cdc42 or Rac1, at levels sufficient to activate the JNK1 pathway, did not induce the Raf-MEK-ERK cascade [6] [7] [8] . We confirmed that constitutively active MEK (MEK-EE; [6] ) and Raf (Raf BXB; [31] ) could potently activate ERK (lanes 6 and 7) . In marked contrast, expression of wild-type, catalytically inactive, or constitutively active hPAK1 failed to induce ERK activity (lanes 3, 4, and 5), which remained at basal levels in these cells (compare lanes 3, 4 and 5 to lane 1). Thus, the activation of the JNK1 MAP kinase pathway by the hPAK1 L107F allele does not reflect general activation of MAP kinase-type pathways.
Discussion
In this report, we have described our investigations of a human Ste20-related kinase, hPAK1. Remarkably, we have found that hPAK1 can replace Ste20 in the mating response pathway of yeast, suggesting that the functions of PAK and Ste20 may be more closely related than previously described. On the basis of PAK function in yeast, we were able to identify a biologically active, constitutive allele of hPAK1, which bypasses the need for activation by hPAK1 complements ste20 in the mating signal transduction pathway. Expression of wild-type hPAK1 and hPAK1 L107F restores mating to a ste20-null strain. Three independent ste20⌬::URA3 colonies expressing the indicated constructs, along with a control Ste20 + strain were replicaplated onto a mating tester lawn of opposite mating type on (a) galactose or (b) glucose media. Permissive mating was performed at 30°C for 10 h on galactose to induce hPAK1 expression, or for 3 h on glucose (no hPAK1 expression), before scoring diploid formation by His + prototrophy, as shown here after 2 days of incubation at 30°C.
Rho-related GTPases. Finally, we used this constitutive allele to show that PAK is likely to be the GTPase effector responsible for activating the JNK MAP kinase pathway.
An expanding family of Ste20-related kinases
Recently, a large number of Ste20-related kinases have been described [16] [17] [18] [19] 26, 32, 33] . To date, these kinases can be broadly divided into two classes which differ in several respects. The first class includes Cla4, rat PAK (p65), PAK65, human hPAK1 (described here), and several others [16] [17] [18] [19] 26] . The second class includes germinal center (GC) kinase and upstream kinase (UK) [32, 33] . Members of the first group are considerably more closely related by sequence to Ste20. They contain a Cdc42-/Rac1-binding domain, and they have an overall structure of regulatory domains amino-terminal to the kinase domain. In contrast, members of the second group are more distantly related to Ste20 by sequence. They have no identifiable GTPase binding domain, and their regulatory domains are carboxyterminal to the kinase domain. Interestingly, mammalian members of both classes, namely hPAK1 kinase and GC kinase, have been shown to activate MAP kinase cascades ( Fig. 4 ; [32, 34, 35] ). The important difference between these two classes of kinases may lie in the inputs that control kinase activity: PAK-related kinases are regulated by Rho-related GTPases [16] , whereas GC/UK kinases may be regulated by distinct signaling components.
Further conservation of the Cdc42/Ste20 pathway?
The yeast pheromone response pathway is a particularly well characterized MAP kinase cascade ( Fig. 6; [1] ). Ste20 activates this pathway in response to signals from both Cdc42 and the heterotrimeric G protein associated with transmembrane pheromone receptors. Although closely related mammalian homologs of Cdc42, Ste20, and MAP kinase cascade components are known, several important proteins in this pathway have no known mammalian counterparts -in particular the SH3-containing protein Bem1 [36] and the proposed MAP kinase scaffold Ste5 [37, 38] . The observation that hPAK1 is capable of coordinating The observation that hPAK1 can complement ste20 is notable in a second regard. Recently, the rat PAK1 protein expressed in ste20 mutants was reported to be unable to support Ste20 function [39] . The difference between these results and ours is particularly interesting in that the hPAK1 reported here differs from rat PAK1 at only eight of 545 amino-acid residues (Fig. 1) . It is possible that one or more of these differences define important protein-interaction interfaces.
Identifying useful alleles of mammalian signaling components by yeast genetics
Using the molecular genetics available in yeast, we were able to isolate a potent constitutively kinase-active hPAK1.
The constitutive activity of this kinase results from a single point mutation located in the Cdc42-binding region, suggesting that this mutation mimics activation by GTP-bound forms of Cdc42 or Rac1. Interestingly, sequence comparison reveals that the leucine residue at position 107 is a conserved residue in the Cdc42-binding domain of Ste20/PAK-related serine/threonine kinases and the ACK non-receptor tyrosine kinase. Construction of constitutive alleles of these proteins should also prove useful in the analysis of their cellular functions.
Possible mechanisms of PAK activation
Biochemical characterization of the hPAK1 L107F kinase suggests that L107F bypasses the need for GTPase-dependent activation of kinase activity. However, we expect that there will be additional mechanisms by which hPAK1 activity can be regulated. This possibility is supported by the finding that hPAK1 L107F produces a more potent kinase activity than wild-type hPAK1 cotransfected with Cdc42 G12V (Fig.  3 ), yet transfection of Cdc42 G12V produces more potent activation of the JNK1 pathway (Fig. 4) . We consider it likely that the subcellular localization of PAK kinase activity will also prove important in the regulation of its function. Perhaps Rho-related GTPases regulate PAK function by inducing conformational activation through binding and by docking PAK at the plasma membrane in the vicinity of its substrates.
The importance of GTPases in localizing effector kinases is demonstrated by the Ras-Raf paradigm: it is proposed that Ras functions by localizing Raf to the plasma membrane, where Raf is activated by Ras-independent mechanisms [3] . Cdc42-PAK regulation is not entirely analogous to Ras-Raf, because binding of Cdc42 to PAK is sufficient to induce kinase activity [16] . A distinct combinatorial mechanism of GTPase-induced conformational activation and localization may be operating in the regulation of Ste20-/PAK-related kinases.
PAK controls the JNK MAP kinase pathway in response to Cdc42 and Rac1
Previously it has been shown that recombinant forms of Cdc42 and Rac1 dramatically activate PAK activity in vitro, and that overexpression of these GTPases leads to activation of the JNK MAP kinase pathway. The results presented in this report, together with the work of others [34, 35] , clearly demonstrate that PAK kinases are GTPase effectors that mediate activation of the JNK kinase pathway.
Where does PAK kinase act in MAP kinase pathways? Evidence from yeast and mammalian cells suggests that
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Figure 6
Ste20 and PAK link Cdc42 to MAP kinase cascades in both yeast and mammals. Model showing the parallels between Ste20/PAK signalling pathways in budding yeast and mammalian cells. In yeast, Cdc42 GTPase activates the serine/threonine kinases Cla4 and Ste20, resulting in cytoskeletal reorganization and Ste20-dependent activation of the pheromone response pathway. We speculate that two analogous pathways may also exist in mammalian cells. Cdc42 and Rac1 have both been shown to regulate cytoskeletal reorganization in mammalian cells; however, the roles of hPAK1 or the JNK pathway in mediating these effects are presently unclear. 
Cdc42
© 1996 Current Biology PAK directly mediates the communication between the Cdc42/Rac1 GTPases and MEKK in the JNK pathway. Ste20 and PAK kinases have been shown to bind to Cdc42 and Rac1 proteins in vitro, and the complementation of ste20 cells by hPAK1 is dependent upon Ste11, the MEKK homolog in the pheromone response pathway. Thus, we conclude that PAK is likely to act as a GTPase-responsive MAPKKKK in the JNK pathway (Fig. 6 ).
Conclusions
In this report, we have shown that the human PAK homolog, hPAK1, acts as a GTPase effector which links the Rho-related GTPases to the JNK MAP kinase pathway. In addition to JNK kinase activation, which leads to c-Jun mediated transcriptional activation, these GTPases have been shown to coordinate mitogenesis and cytoskeletal rearrangements [8] [9] [10] [11] [12] [13] [14] [15] . An important issue remaining to be addressed is the nature of the branching in these signaling pathways that allows these GTPases to control such diverse effects. It is worth noting that the cytoskeletal changes mediated by injection of Rac1 or Cdc42 proteins are probably too rapid to result from transcriptional induction by the JNK pathway and c-Jun. However several additional possibilities merit consideration. Firstly, the components of the JNK pathway may play a direct role in cytoskeletal responses in addition to nuclear responses; secondly, PAKs may have additional targets involved in cytoskeletal rearrangement; and thirdly, the cytoskeletal changes elicited by Rho-related GTPases may be produced by effectors unrelated to PAK. Understanding the mechanisms by which cells coordinate these responses should provide valuable information on how these signaling pathways may be adapted to the regulation of multiple cellular functions.
Materials and methods
Isolation of human hPAK1
Degenerate oligonucleotide primers (TGGT(CG)AT(AT)A(TC)GGA-(AG)TACATG and TA(TA)GG(CA)GG(TC)TC(AC)CC(TC)TC(TG)AT-CAT), based upon conserved regions within the kinase domains of Ste20 and Scprokin (GenBank accession number X69322) were used to PCR amplify first strand cDNA derived from the Dami megakaryocyterelated cell line. A PCR product was identified and used to probe a human placental cDNA library [29] . A 2.0 kb cDNA fragment was initially identified, and was used to reprobe the placental cDNA library to isolate a second 3.2 kb cDNA. The full-length hPAK1 was assembled by ligation of a BamHI-StuI fragment of the 3.2 kb clone into the BamHI-StuI sites of the 2.0 kb fragment in the vector Bluescript KS + (Stratagene). The insert was sequenced on both strands and is predicted to encode a protein of 545 amino acids, with a molecular mass of 61 kDa. A plasmid encoding a functional hPAK1 with an amino-terminal HA tag was constructed, from which a HA-tagged catalytically inactive hPAK1 (K299A) was made, using Kunkel mutagenesis [40] and oligonucleotide primers (HA, CTGGTGGTGACAGGTACCAT-GGACGTGCCGGACTACGC-TTCCTCAAATAACGCCTA; and K299A, GAGGTGGCCATTGCGCA-GATGAATCTT). HA-tagged versions of hPAK1 were used in all experiments described.
Accession number
The GenBank accession number for the hPAK1 sequence is U51120.
hPAK1 complementation of ste20 HA-tagged hPAK1, hPAK1 L107F (see below) and hPAK1 K299A were expressed from 2.2 kb KpnI fragments subcloned into a pRS315-based vector [41] containing the yeast GAL1 promotor and the LEU2 selectable marker (plasmids pGAL1-hPAK1, pGAL1-hPAK1 L107F and pGAL1-hPAK1 K299A , respectively). Each plasmid, and the vector alone, were transformed into strain MATa ste20⌬::URA3 his3 ura3 leu2 ade2 lys2, and three independent transformants of each construct were patched on synthetic complete (SC) plates lacking leucine [42] . Patches were then replica-plated onto a mating tester lawn (JC27: MAT␣ his4 trp1 ura3) on either YPD plates or YPGal plates to induce hPAK1 expression. Mating reactions were incubated at 30°C for 10 h on galactose, or 3 h on glucose, and replica-plated to SC glucose plates lacking histidine to assay for diploid formation (His + ).
Isolation of constitutively active hPAK1 kinase
The pGAL1-hPAK1 plasmid (described above) was chemically mutagenized with hydroxylamine [42] , amplified in E. coli, and transformed into yeast strain JC66 (MATa leu2 ura3 trp1 ). Approximately 40 000 transformants were screened for slowed growth in SC galactose plates lacking leucine [43] . Six such plasmids were isolated, one of which (hPAK1.36) led to constitutive activation of pheromone induced transcription assayed with a FUS1::lacZ reporter [41] . The sequence of this clone revealed the presence of three point mutations, and separation of these mutations indicated that the constitutive activity was due entirely to an L107F mutation. All further experiments were performed with the single L107F mutant denoted hPAK1 L107F .
Mammalian cell culture and transfections
For all transient transfections COS-7 cells were grown in RPMI-1640 medium (Gibco BRL) supplemented with 10 % fetal bovine serum (Hyclone), 60 g ml -1 glutamine, 10 U ml -1 penicillin and 10 U ml -1 streptomycin. Subconfluent cells were transfected in 100 mm dishes using the Lipofectamine reagent (Gibco BRL) with DNA at a constant 8 g per plate (supplemented with pCDNA3 vector when necessary). Cells were serum starved for 16 h prior to kinase assays which were performed 48 h following transfection. To investigate the possibility that JNK1 activation observed in this report was produced by an autocrine loop rather than an intracellular signaling pathway, culture supernatants from cells transfected with plasmids expressing Cdc42 G12V or PAK L107F were added to cells transfected with HA-JNK alone. Culture supernatants had little or no effect upon JNK1 activity (J.L.B., unpublished observations).
Immunoprecipitations and kinase assays
Cells were washed twice with PBS containing 5 mM EDTA, and lysed at 4°C in lysis buffer (150 mM NaCl, 50 mM Tris (pH 8.0), 1 mM EDTA, 0.1 % Triton X-100, 1 mg ml -1 bovine serum albumin, 1 mM PMSF, 10 g ml -1 aprotinin and 10 g ml -1 leupeptin). Typically, immunoprecipitations were performed with 6 g monoclonal 12CA5 antibody (anti-HA) for HA-hPAK1 or HA-JNK1 (Boehringer Mannheim), or with a similar amount of anti-ERK polyclonal antiserum (Santa Cruz Biotechnology Inc.). Immune complexes, formed by incubation at 4°C for 1 h, were recovered by adding protein A beads (Pierce) and centrifuging. Beads were washed twice in lysis buffer and twice in kinase buffer (100 mM NaCl, 50 mM Tris (pH 7.5), 10 mM MgCl 2 and 1 mM MnCl 2 ). Kinase assays were performed in 50 l reactions with 10 mM ATP, 1 Ci ␥-[ 32 P]ATP and either 3 g MBP (Sigma) or GST-tagged c-Jun (amino acids 1-79; [4] ). After 20 min at 30°C, reactions were terminated by addition of 10 l 5 × Laemmli sample buffer [44] , heated to 95°C and separated by SDS-PAGE [44] . Autoradiographs were typically exposed for 30-40 min with an intensifier screen.
Western blots of protein extracts or immunoprecipitated proteins were performed using standard methods [44] . Measurement of MBP or cJun phosphorylation was performed by excising bands from the SDS-PAGE gel shown in each figure, and determining radioactivity (cpm) using a Beckman LS6000 IC scintilation counter. Numbers reported are relative values compared to transfections with vector plus HA-hPAK1 construct (Fig. 3) , vector plus JNK1 construct (Fig. 4) , and vector plus ERK2 construct (Fig. 5 ).
